Insider Selling: AngioDynamics, Inc. (NASDAQ:ANGO) SVP Sells 4,060 Shares of Stock

by · The Cerbat Gem

AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) SVP Warren Nighan, Jr. sold 4,060 shares of the firm’s stock in a transaction on Thursday, January 16th. The shares were sold at an average price of $12.31, for a total value of $49,978.60. Following the completion of the sale, the senior vice president now directly owns 41,817 shares in the company, valued at approximately $514,767.27. This represents a 8.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

AngioDynamics Stock Performance

Shares of NASDAQ ANGO traded down $0.34 during trading hours on Friday, hitting $12.43. The company’s stock had a trading volume of 551,541 shares, compared to its average volume of 1,233,167. The stock has a market cap of $503.04 million, a price-to-earnings ratio of -2.21 and a beta of 0.59. The business has a 50-day simple moving average of $8.65 and a 200-day simple moving average of $7.60. AngioDynamics, Inc. has a 12 month low of $5.26 and a 12 month high of $13.13.

AngioDynamics (NASDAQ:ANGO – Get Free Report) last issued its earnings results on Wednesday, January 8th. The medical instruments supplier reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.07. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The business had revenue of $72.90 million during the quarter, compared to analysts’ expectations of $70.93 million. During the same period in the previous year, the company earned ($0.05) earnings per share. The business’s revenue for the quarter was down .1% compared to the same quarter last year. On average, equities research analysts forecast that AngioDynamics, Inc. will post -0.36 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Quarry LP grew its position in shares of AngioDynamics by 40.9% during the third quarter. Quarry LP now owns 8,518 shares of the medical instruments supplier’s stock worth $66,000 after purchasing an additional 2,471 shares in the last quarter. SG Americas Securities LLC increased its position in shares of AngioDynamics by 21.3% during the 4th quarter. SG Americas Securities LLC now owns 16,102 shares of the medical instruments supplier’s stock valued at $147,000 after purchasing an additional 2,832 shares during the last quarter. CWM LLC raised its position in AngioDynamics by 981.3% in the 3rd quarter. CWM LLC now owns 9,732 shares of the medical instruments supplier’s stock worth $76,000 after purchasing an additional 8,832 shares during the period. Wealth Enhancement Advisory Services LLC bought a new position in shares of AngioDynamics in the third quarter worth about $86,000. Finally, Charles Schwab Investment Management Inc. increased its holdings in AngioDynamics by 3.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 326,820 shares of the medical instruments supplier’s stock worth $2,543,000 after purchasing an additional 11,599 shares during the period. 89.43% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ANGO has been the topic of several recent research reports. Canaccord Genuity Group cut their target price on AngioDynamics from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, October 4th. HC Wainwright increased their price target on AngioDynamics from $14.00 to $15.00 and gave the company a “buy” rating in a research report on Friday, January 10th.

Read Our Latest Analysis on ANGO

About AngioDynamics

(Get Free Report)

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.

Further Reading